Dr. Gross is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- Oregon Health & Science University (OHSU Health)Residency, Otolaryngology - Head and Neck Surgery, 1999 - 2003
- Oregon Health and Science University School of MedicineClass of 1998
- Washington UniversityB.A., Biology, with Honors, 1994
Certifications & Licensure
- FL State Medical License 2021 - Present
- OR State Medical License 2006 - Present
- TX State Medical License Active through 2026
- OK State Medical License 2020 - 2021
- NY State Medical License 2003 - 2006
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
- ACGMEOtolaryngology
Awards, Honors, & Recognition
- Faculty Teaching Award, Department of Head and Neck Surgery 2014
- Fellow-At-Large American Head and Neck Society, 2013
- Honor Award AAO-HNS, 2012
- Join now to see all
Clinical Trials
- Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery Start of enrollment: 2018 Jul 03
Roles: Contact, Principal Investigator
- Intensity-Modulated Proton Therapy (IMPT) or TransOral Robotic Surgery (TORS) for the Treatment of Low-Risk Oropharynx Squamous Cell Start of enrollment: 2016 Jan 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Spatial transcriptomics reveal tumor microenvironment and SLCO2A1 correlated with tumor suppression in hypopharyngeal squamous cell carcinoma.Ce Li, Chenyang Xu, Rui Guan, Ruijie Jiao, Yin Wang
International Immunopharmacology. 2024-12-05 - 2 citationsImpact of pretreatment body mass index on the survival of head and neck cancer patients.Zheng Yang, Jobran Mansour, Peng Sun, Peng Wei, Kristina R Dahlstrom
Head & Neck. 2024-08-01 - Immune checkpoint inhibitors with or without chemotherapy for orbital, conjunctival, and ocular adnexal squamous cell carcinoma.Bita Esmaeli, Janet Fan, Hila Goldberg, Tracy Lu, Neil D Gross
Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2024-07-20
Journal Articles
- Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaScott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
- Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaJanice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
- Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaRichard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Tracheal recurrences in HPV positive SCC.Chen M (presenting), Gross ND, ASNR 56th Annual Meeting, 1/1/2018
- Facilitating rapid precision oncology in anaplastic thyroid cancer: Clinical implications of next generation sequencing (NGS) mutation testing and impact on survival.Wang J (Presenting), Gross ND, ASCO Annual Meeting, 1/1/2018
- Evidence Supporting Free Head and Neck Cancer Screening.Urdang Z (Presenting), Gross ND, American Academy of Otolaryngology - Head and Neck Surgery Annual Meeting, Chicago, IL, 1/1/2017
- Join now to see all
Lectures
- Panel: Thyroid & ParathyroidVail, CO - 1/5/2018
- Adjuvant Treatment Decision Making after TORSLausanne, Switzerland - 1/30/2017
- Parathyroid CasesUniversity of Colorado, Vail, CO - 1/30/2017
- Join now to see all
Other
- Treatment of Advanced (Stage III and IV) Head and Neck Cancer: The Oral Cavity.Gross ND, Lee N, Wu A, Okuno S, UptoDate
1/1/2016 - Treatment of Early (Stage I and II) Head and Neck Cancer: The Oral Cavity.Gross ND, Lee N, Wu A, Okuno S, UptoDate
1/1/2016 - Contemporary Adjunctive Cancer Therapy, 3rd.Gross ND, American Academy of Otolaryngology Head and Neck Surgery
1/1/2015 - Join now to see all
Press Mentions
- Welcome to the AAO-HNSF 2024 Annual Meeting Program ScheduleSeptember 16th, 2024
- New Cancer Survival Calculator Focuses on Oral CancerJuly 24th, 2023
- What Men Need to Know About HPV-Related Throat CancerMarch 3rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: